Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns. Jabagi MJ, Bertrand M, Gabet A, Kolla E, et al. JAMA 2025 Dec 22:e2524082. doi: 10.1001/jama.2025.24082.

Read + Share

Amedeo Smart

Independent Medical Education

Jabagi MJ, Bertrand M, Gabet A, Kolla E, et al. Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns. JAMA 2025 Dec 22:e2524082. doi: 10.1001/jama.2025.24082.
PMID: 41428474